Cargando…

NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects

PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline varian...

Descripción completa

Detalles Bibliográficos
Autores principales: Belhadj, Sami, Khurram, Aliya, Bandlamudi, Chaitanya, Palou-Márquez, Guillermo, Ravichandran, Vignesh, Steinsnyder, Zoe, Wildman, Temima, Catchings, Amanda, Kemel, Yelena, Mukherjee, Semanti, Fesko, Benjamin, Arora, Kanika, Mehine, Miika, Dandiker, Sita, Izhar, Aalin, Petrini, John, Domchek, Susan, Nathanson, Katherine L., Brower, Jamie, Couch, Fergus, Stadler, Zsofia, Robson, Mark, Walsh, Michael, Vijai, Joseph, Berger, Michael, Supek, Fran, Karam, Rachid, Topka, Sabine, Offit, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843434/
https://www.ncbi.nlm.nih.gov/pubmed/36346689
http://dx.doi.org/10.1158/1078-0432.CCR-22-1703
_version_ 1784870401758724096
author Belhadj, Sami
Khurram, Aliya
Bandlamudi, Chaitanya
Palou-Márquez, Guillermo
Ravichandran, Vignesh
Steinsnyder, Zoe
Wildman, Temima
Catchings, Amanda
Kemel, Yelena
Mukherjee, Semanti
Fesko, Benjamin
Arora, Kanika
Mehine, Miika
Dandiker, Sita
Izhar, Aalin
Petrini, John
Domchek, Susan
Nathanson, Katherine L.
Brower, Jamie
Couch, Fergus
Stadler, Zsofia
Robson, Mark
Walsh, Michael
Vijai, Joseph
Berger, Michael
Supek, Fran
Karam, Rachid
Topka, Sabine
Offit, Kenneth
author_facet Belhadj, Sami
Khurram, Aliya
Bandlamudi, Chaitanya
Palou-Márquez, Guillermo
Ravichandran, Vignesh
Steinsnyder, Zoe
Wildman, Temima
Catchings, Amanda
Kemel, Yelena
Mukherjee, Semanti
Fesko, Benjamin
Arora, Kanika
Mehine, Miika
Dandiker, Sita
Izhar, Aalin
Petrini, John
Domchek, Susan
Nathanson, Katherine L.
Brower, Jamie
Couch, Fergus
Stadler, Zsofia
Robson, Mark
Walsh, Michael
Vijai, Joseph
Berger, Michael
Supek, Fran
Karam, Rachid
Topka, Sabine
Offit, Kenneth
author_sort Belhadj, Sami
collection PubMed
description PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline variants (PGV) identified. Allele-specific and gene-centered analysis of enrichment was conducted and a validation cohort of 26,407 pan-cancer patients was analyzed. Functional studies utilized cellular models with analysis of protein expression, MRN complex formation/localization, and viability assessment following treatment with γ-irradiation. RESULTS: We identified 83 carriers of 32 NBN PGVs (0.25% of the studied series), 40% of which (33/83) carried the Slavic founder p.K219fs. The frequency of PGVs varied across cancer types. Patients harboring NBN PGVs demonstrated increased loss of the wild-type allele in their tumors [OR = 2.7; confidence interval (CI): 1.4–5.5; P = 0.0024; pan-cancer], including lung and pancreatic tumors compared with breast and colorectal cancers. p.K219fs was enriched across all tumor types (OR = 2.22; CI: 1.3–3.6; P = 0.0018). Gene-centered analysis revealed enrichment of PGVs in cases compared with controls in the European population (OR = 1.9; CI: 1.3–2.7; P = 0.0004), a finding confirmed in the replication cohort (OR = 1.8; CI: 1.2–2.6; P = 0.003). Two novel truncating variants, p.L19* and p.N71fs, produced a 45 kDa fragment generated by alternative translation initiation that maintained binding to MRE11. Cells expressing these fragments showed higher sensitivity to γ-irradiation and lower levels of radiation-induced KAP1 phosphorylation. CONCLUSIONS: Burden analyses, biallelic inactivation, and functional evidence support the role of NBN as contributing to a broad cancer spectrum. Further studies in large pan-cancer series and the assessment of epistatic and environmental interactions are warranted to further define these associations.
format Online
Article
Text
id pubmed-9843434
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-98434342023-01-19 NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects Belhadj, Sami Khurram, Aliya Bandlamudi, Chaitanya Palou-Márquez, Guillermo Ravichandran, Vignesh Steinsnyder, Zoe Wildman, Temima Catchings, Amanda Kemel, Yelena Mukherjee, Semanti Fesko, Benjamin Arora, Kanika Mehine, Miika Dandiker, Sita Izhar, Aalin Petrini, John Domchek, Susan Nathanson, Katherine L. Brower, Jamie Couch, Fergus Stadler, Zsofia Robson, Mark Walsh, Michael Vijai, Joseph Berger, Michael Supek, Fran Karam, Rachid Topka, Sabine Offit, Kenneth Clin Cancer Res Translational Cancer Mechanisms and Therapy PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline variants (PGV) identified. Allele-specific and gene-centered analysis of enrichment was conducted and a validation cohort of 26,407 pan-cancer patients was analyzed. Functional studies utilized cellular models with analysis of protein expression, MRN complex formation/localization, and viability assessment following treatment with γ-irradiation. RESULTS: We identified 83 carriers of 32 NBN PGVs (0.25% of the studied series), 40% of which (33/83) carried the Slavic founder p.K219fs. The frequency of PGVs varied across cancer types. Patients harboring NBN PGVs demonstrated increased loss of the wild-type allele in their tumors [OR = 2.7; confidence interval (CI): 1.4–5.5; P = 0.0024; pan-cancer], including lung and pancreatic tumors compared with breast and colorectal cancers. p.K219fs was enriched across all tumor types (OR = 2.22; CI: 1.3–3.6; P = 0.0018). Gene-centered analysis revealed enrichment of PGVs in cases compared with controls in the European population (OR = 1.9; CI: 1.3–2.7; P = 0.0004), a finding confirmed in the replication cohort (OR = 1.8; CI: 1.2–2.6; P = 0.003). Two novel truncating variants, p.L19* and p.N71fs, produced a 45 kDa fragment generated by alternative translation initiation that maintained binding to MRE11. Cells expressing these fragments showed higher sensitivity to γ-irradiation and lower levels of radiation-induced KAP1 phosphorylation. CONCLUSIONS: Burden analyses, biallelic inactivation, and functional evidence support the role of NBN as contributing to a broad cancer spectrum. Further studies in large pan-cancer series and the assessment of epistatic and environmental interactions are warranted to further define these associations. American Association for Cancer Research 2023-01-17 2022-11-08 /pmc/articles/PMC9843434/ /pubmed/36346689 http://dx.doi.org/10.1158/1078-0432.CCR-22-1703 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
spellingShingle Translational Cancer Mechanisms and Therapy
Belhadj, Sami
Khurram, Aliya
Bandlamudi, Chaitanya
Palou-Márquez, Guillermo
Ravichandran, Vignesh
Steinsnyder, Zoe
Wildman, Temima
Catchings, Amanda
Kemel, Yelena
Mukherjee, Semanti
Fesko, Benjamin
Arora, Kanika
Mehine, Miika
Dandiker, Sita
Izhar, Aalin
Petrini, John
Domchek, Susan
Nathanson, Katherine L.
Brower, Jamie
Couch, Fergus
Stadler, Zsofia
Robson, Mark
Walsh, Michael
Vijai, Joseph
Berger, Michael
Supek, Fran
Karam, Rachid
Topka, Sabine
Offit, Kenneth
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
title NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
title_full NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
title_fullStr NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
title_full_unstemmed NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
title_short NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
title_sort nbn pathogenic germline variants are associated with pan-cancer susceptibility and in vitro dna damage response defects
topic Translational Cancer Mechanisms and Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843434/
https://www.ncbi.nlm.nih.gov/pubmed/36346689
http://dx.doi.org/10.1158/1078-0432.CCR-22-1703
work_keys_str_mv AT belhadjsami nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT khurramaliya nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT bandlamudichaitanya nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT paloumarquezguillermo nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT ravichandranvignesh nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT steinsnyderzoe nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT wildmantemima nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT catchingsamanda nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT kemelyelena nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT mukherjeesemanti nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT feskobenjamin nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT arorakanika nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT mehinemiika nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT dandikersita nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT izharaalin nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT petrinijohn nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT domcheksusan nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT nathansonkatherinel nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT browerjamie nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT couchfergus nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT stadlerzsofia nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT robsonmark nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT walshmichael nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT vijaijoseph nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT bergermichael nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT supekfran nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT karamrachid nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT topkasabine nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects
AT offitkenneth nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects